David_Sancho
    About the CNIC, Research
    David Sancho receives the 22nd Health Sciences Award from the Caja Rural Granada Foundation

    The Foundation recognises the pioneering research into the link between gut microbiota and cardiovascular disease led by David Sancho at the CNIC 

    Annalaura Mastrangelo
    About the CNIC, Research
    Researcher Annalaura Mastrangelo receives the 2026 Young Investigator Award in the Basic Science category
    Optimal dendritic-cell-based antitumor immunotherapy with cDC1 cells requires active mitochondria. Whereas vaccination with normal cDC1 cells efficiently reduces metastasis in B16-OVA tumors, the antitumor efficacy of these cells is diminished when their mitochondria are damaged.
    Research, Publications
    Science Immunology: Mitochondria control immune cell activation and the effectiveness of immunotherapy

    A CNIC-led study identifies a mitochondrial “checkpoint” that enables dendritic cells to efficiently activate T lymphocytes against viruses and tumors

    David Sancho, Ignacio Heras-Murillo y Stefanie Wculek.
    Research, Publications
    Mitochondria keep immune cells “ready to respond”

    Scientist at the Centro Nacional de Investigaciones Cardiovasculares Carlos III (CNIC) and the Institute for Research in Biomedicine (IRB Barcelona) uncover a key metabolic mechanism governing immune cell readiness

    •  
    • 1 of 6